Inhibiting effect of feprazone on "in vitro" human platelet aggregation.
Explore the source record for details and available documents.
Adenosine Diphosphate↗
Biomedical subjects
G Bonardi
Publications and source records attributed to G Bonardi.
New method for quantitative determination of D-dopa in levodopa samples.
Explore the source record for details and available documents.
Amino Acid Oxidoreductases↗
Effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370, fenilprenazone) on lysosomes.
Explore the source record for details and available documents.
Acid Phosphatase↗
Pharmacological and toxicological properties of 19-nortestosterone-homofarnesta (DA 1979), a new anabolic agent.
Explore the source record for details and available documents.
Alkaline Phosphatase↗
Hormonal properties of 19-nortestosterone-homofarnesate (DA 1979), a new anabolic agent.
Explore the source record for details and available documents.
Anabolic Agents↗
Quantitative biochemical changes in rats following isoproterenol-induced myocardial infarction.
Explore the source record for details and available documents.
Alanine Transaminase↗
Experimental models for the in vivo evaluation of enzyme induction properties of drugs.
Explore the source record for details and available documents.
Acetanilides↗
Quantitative determination of D-dopa present in levodopa samples.
Explore the source record for details and available documents.
Amino Acids↗
Simple quantitative method for determining 3-methoxy-4-hydroxyphenylacetic acid and 3,4-dihydroxyphenylacetic acid in urine.
Explore the source record for details and available documents.
Catechols↗
Terpene compounds as drugs. 11. Anabolic 19-nortestosterone terpenoates.
Explore the source record for details and available documents.
Animals↗
Terpene compounds as drugs. 13. o-Terpenylaminomethylphenols and their N-methyl derivatives.
Explore the source record for details and available documents.
Amino Alcohols↗
Experimental gastric ulcers and stomach tissue pepsin activity in the rat.
Explore the source record for details and available documents.
Animals↗
Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. General pharmacological properties.
Explore the source record for details and available documents.
Aminopyrine↗
Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Subacute and chronic toxicity in rats and dogs.
Explore the source record for details and available documents.
Administration, Oral↗
Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
Explore the source record for details and available documents.
Administration, Oral↗
Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Action on local and systemic chemical responses in the rat with an experimental inflammatory process.
Explore the source record for details and available documents.
Animals↗
Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 4. Effects on erythrocyte membrane lysis and on red cells aggregation.
Explore the source record for details and available documents.
Animals↗
[Changes in local and systemic parameters in the rat exposed to an inflammatory process. I].
Explore the source record for details and available documents.
Animals↗